Skip to main content
OpenTrials
Completed

NCT Number: NCT07267312

Premature Coronary Artery Disease and Familial Dyslipidemia in Patients Presenting With Acute Coronary Syndrome

This study aimed to explore the relationship between familial hypercholesterolemia and premature coronary artery disease, particularly in the context of acute coronary syndrome, by reviewing current evidence and highlighting the need for improved screening and aggressive lipid-lowering strategies in high-risk populations.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Dyslipidaemia and familial hypercholesterolemia (FH) are a common disorder that causes premature coronary artery disease.

The lifelong burden of elevated low-density lipoprotein cholesterol (LDL-C) in FH accelerates endothelial dysfunction and plaque formation, often culminating in acute coronary syndrome (ACS) at a young age. ACS in patients with undiagnosed FH may be their first clinical manifestation, underscoring the importance of early identification and intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years at the time of presentation.
  • Both sexes.
  • Confirmed diagnosis of coronary artery disease (CAD), established by clinical presentation, electrocardiographic findings, elevated cardiac biomarkers, and/or angiographic evidence of ≥50% luminal stenosis in at least one major coronary artery.
  • Hospital admission to the participating cardiology department between [insert study period, e.g., January 2020 and December 2024] for acute coronary syndrome (ACS), including unstable angina, non-ST-elevation myocardial infarction (NSTEMI), or ST-elevation myocardial infarction (STEMI).
  • Availability of complete clinical, laboratory, and echocardiographic data necessary for classification and analysis.

Exclusion criteria

  • Incomplete medical records or missing essential laboratory, imaging, or demographic data.
  • Secondary causes of dyslipidemia, including uncontrolled hypothyroidism, nephrotic syndrome, chronic liver disease, or use of lipid-altering medications (other than statins) before presentation.
  • Previous congenital or structural heart disease, cardiomyopathy, or significant valvular heart disease unrelated to CAD.
  • Severe chronic kidney disease (estimated glomerular filtration rate <30 mL/min/1.73 m²) or patients on dialysis.
  • Autoimmune, inflammatory, or systemic diseases known to influence vascular inflammation or lipid metabolism.
  • Malignancy or life expectancy <6 months due to non-cardiac causes.
  • Pregnant or lactating women.
  • Non-Saudi patients (focusing on Saudi population in southern region).

Treatment and study plan

Cardiovascular risk assessment

Other

Participants underwent a standardized cardiovascular risk assessment that included detailed clinical evaluation, lipid profiling (Total Cholesterol, Low-Density Lipoprotein Cholesterol, High-Density Lipoprotein Cholesterol, and Triglycerides).

Primary outcomes

  1. Dyslipidemia pattern in patients with acute coronary syndrome

    Time frame: Within 24 hours of hospital admission

    Dyslipidemia pattern in patients with acute coronary syndrome was recorded.

  2. Incidence of familial dyslipidemia among patients with acute coronary syndrome

    Time frame: Within 24 hours of hospital admission

    Incidence of familial dyslipidemia among patients with acute coronary syndrome was recorded.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Premature Coronary Artery Disease and Familial Dyslipidemia in Patients Presenting With Acute Coronary Syndrome: A Tertiary Cardiac Center Registry

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
Dec 5, 2025
Registry last updated
Dec 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.